ABOUT
Aims and scope
About the journal
Editorial board
Open access
Subscription information
Editorial board meeting
BROWSE ARTICLES
All issues
Current issue
Snapshot
Ahead-of-print articles
Most viewed articles
Most cited articles
FOR CONTRIBUTORS
Publish with CMH
Instructions for authors
Peer review and publishing
Checklist
E-Submission
Copyright transfer form
Search
Close
Editorials
Clinical impact of five cardiometabolic risk factors in metabolic dysfunction-associated steatotic liver disease (MASLD): Insights into regional and ethnic differences
Joo Hyun Oh, Dae Won Jun
Clin Mol Hepatol. 2024;30(2):168-170.
Erratums
Erratum to ‘Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?’ [Clin Mol Hepatol 2023;29:367-370]
Joo Hyun Oh, Dong Hyun Sinn
Clin Mol Hepatol. 2023;29(3):828-829.
Correspondences
Correspondence on Letter regarding “Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?”
Joo Hyun Oh, Dong Hyun Sinn
Clin Mol Hepatol. 2023;29(3):820-820.
Editorials
Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?
Joo Hyun Oh, Dong Hyun Sinn
Clin Mol Hepatol. 2023;29(2):367-370.
The latest global burden of liver cancer: A past and present threat
Joo Hyun Oh, Dae Won Jun
Clin Mol Hepatol. 2023;29(2):355-357.